Cardiology in Review

Cardiology in Review (ISSN 1061-5377) is a distinguished bi-monthly academic journal published in the United States by Lippincott Williams & Wilkins, a leading imprint within the Wolters Kluwer portfolio. Dedicated to the comprehensive study of cardiovascular medicine, the journal serves as a vital bridge between rigorous clinical practice and cutting-edge research, covering a broad spectrum of subfields including general cardiology, hypertension, arrhythmias, and heart failure. Indexed in the Science Citation Index (SCI), it maintains a high standard of editorial integrity through a rigorous peer-review process that ensures the publication of high-quality clinical studies, diagnostic innovations, therapeutic advancements, and preventive strategies. While the journal operates under a non-open access model, which may influence immediate reader accessibility, it remains a respected authority in the field, with its impact factor and Chinese Academy of Sciences (CAS) ranking reflecting its standing among competitive cardiovascular publications; researchers and clinicians are advised to consult the latest data for current metrics, as these indicators can fluctuate based on submission volumes and competitive dynamics within the specialty.